Compared with previous observational studies, soluble receptors for advanced glycation end-products (sRAGE), liver-expressed antimicrobial peptide 2 (LEAP2), and allograft inflammatory factor-1 (AIF1) were positively associated with CKD or decreased eGFR and were consistent with our findings. This evidence concerns the gene AIF1 and chronic kidney disease.